ENTA vs SPG · rev $65.3M vs rev $3.55B
Enanta Pharmaceuticals Inc (ENTA) versus SPG (SPG) — a side-by-side from cached financials, not a winner call.
Enanta Pharmaceuticals Inc (ENTA) is a biotechnology company listed on US.
SPG (SPG) common stock.
Latest reported ENTA revenue for 2025-09-30 was $65.3M. Net income was -$81.9M. ENTA currently screens at market cap $328.0M.
Latest reported SPG revenue for 2026-06-30 was $3.55B. Net income was $1.14B. SPG currently screens at market cap $0.
ENTA currently screens at market cap $328.0M. SPG currently screens at market cap $0.
Not investment advice. Open the ENTA and SPG stock pages for the full models.
Not investment advice.